Germany
Japan
United Kingdom
China
NEK8 Rabbit Polyclonal Antibody
| Applications | ICC/IF, WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Recombinant protein of human NEK8 |
Primary Antibodies
DownloadERK2 (MAPK1) (N-term) rabbit polyclonal antibody, Aff - Purified
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | A synthetic peptide corresponding to a sequence at the N-terminal of human ERK2 |
TrkA (NTRK1) rabbit polyclonal antibody, Aff - Purified
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | A synthetic peptide corresponding to a sequence at the middle region of human Trk-A |
Rabbit polyclonal Met (Tyr1349) antibody(Phospho-specific)
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human Met around the phosphorylation site of tyrosine 1349 (E-H-YP-V-H). |
| Modifications | Phospho-specific |
Rabbit polyclonal PKC e (Ser729) antibody(Phospho-specific)
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human PKC e around the phosphorylation site of serine 729 (G-F-SP-Y-F). |
| Modifications | Phospho-specific |
Rabbit polyclonal EGFR (Tyr869) antibody(Phospho-specific)
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human EGFR around the phosphorylation site of tyrosine 869 (K-E-YP-H-A). |
| Modifications | Phospho-specific |
Rabbit polyclonal EGFR (Tyr1110) antibody(Phospho-specific)
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human EGFR around the phosphorylation site of tyrosine 1110 (P-V-YP-H-N). |
| Modifications | Phospho-specific |
Rabbit polyclonal HCK (Tyr521) antibody(Phospho-specific)
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human HCK around the phosphorylation site of tyrosine 521. |
| Modifications | Phospho-specific |
Rabbit polyclonal Zap-70 (Tyr319) antibody(Phospho-specific)
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human Zap-70 around the phosphorylation site of tyrosine 319 (S-P-YP-S-D). |
| Modifications | Phospho-specific |
PRKAA1 Rabbit Polyclonal Antibody
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | Recombinant protein of human PRKAA1 |
Phospho-JAK2-Y221 Rabbit Polyclonal Antibody
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | A phospho specific peptide corresponding to residues surrounding Y221 of human JAK2 |
| Modifications | Phospho-specific |
Phospho-PRKAA1-T174/T172 Rabbit Polyclonal Antibody
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | A phospho specific peptide corresponding to residues surrounding T174/T172 of human PRKAA1 |
| Modifications | Phospho-specific |
Active filters
Applications
- WB
Isotypes
- IgG
Clonalities
- Polyclonal
Families
- Protein Kinase
Filter by
Target Symbol
- AKT1 (36)
- EGFR (36)
- HER2 (18)
- CHK1 (17)
- PKC DELTA (16)
- JAK2 (15)
- VEGF RECEPTOR 2 (15)
- CHK2 (14)
- MCSF RECEPTOR (14)
- ERK2 (13)
- MET (13)
- P38 (13)
- RAF1 (13)
- S6K1 (13)
- GSK3 BETA (12)
- LCK (12)
- PKC ALPHA (12)
- ROCK2 (12)
- CDK1 (11)
- FAK (11)
- GSK3 ALPHA (11)
- PAK1 (11)
- PDGF RECEPTOR BETA (11)
- SYK (11)
- B RAF (10)
- ERK1 (10)
- IKK ALPHA (10)
- MEK1 (10)
- SRC (10)
- TAK1 (10)
- AMPK ALPHA 1 (9)
- ASK1 (9)
- C ABL (9)
- CDK2 (9)
- EPH RECEPTOR A2 (9)
- FGFR1 (9)
- FYN (9)
- IGF1 RECEPTOR (9)
- IKK BETA (9)
- JNK1 (9)
- LIM KINASE 2 (9)
- ZAP70 (9)
- CD117 (8)
- CDK7 (8)
- STK39 (8)
- AURORA A (7)
- CDK5 (7)
- CDK9 (7)
- LIM KINASE 1 (7)
- MAPKAP KINASE 2 (7)
- MEK6 (7)
- MSK1 (7)
- PKC BETA 1 (7)
- PRKACA (7)
- RIP2 (7)
- RON (7)
- TRKB (7)
- AKT2 (6)
- BTK (6)
- CAMK1D (6)
- CAMK2A (6)
- EPH RECEPTOR A3 (6)
- GRK2 (6)
- GRK5 (6)
- INSULIN RECEPTOR (6)
- IRAKM (6)
- JAK1 (6)
- MAP3K8 (6)
- MEK4 (6)
- MERTK (6)
- MNK1 (6)
- MOK PROTEIN KINASE (6)
- MTOR (6)
- PAK2 (6)
- PKC GAMMA (6)
- PKC ZETA (6)
- TGF BETA RECEPTOR II (6)
- ACK1 (5)
- AURORA C (5)
- BCR (5)
- BMX (5)
- CASEIN KINASE 1 ALPHA (5)
- CSK (5)
- DNA PKCS (5)
- DRAK1 (5)
- EPH RECEPTOR A7 (5)
- FER (5)
- FGR (5)
- FLT3 (5)
- HCK (5)
- LKB1 (5)
- LYN (5)
- MCK10 (5)
- MEK2 (5)
- NEK2 (5)
- P70 S6 KINASE BETA (5)
- PDGF RECEPTOR ALPHA (5)
- PDK1 (5)
- PDK2 (5)
- PDPK1 (5)
Reactivities
Antibody Hosts
Conjugates
Modifications
Assay Types
Pathways
- MAPK signaling pathway (442)
- Pathways in cancer (394)
- Focal adhesion (352)
- ErbB signaling pathway (328)
- Chemokine signaling pathway (293)
- Neurotrophin signaling pathway (292)
- Prostate cancer (253)
- T cell receptor signaling pathway (245)
- Insulin signaling pathway (230)
- Fc epsilon RI signaling pathway (228)
- GnRH signaling pathway (228)
- Glioma (221)
- Colorectal cancer (220)
- Pancreatic cancer (219)
- Regulation of actin cytoskeleton (216)
- Progesterone-mediated oocyte maturation (209)
- Fc gamma R-mediated phagocytosis (203)
- Non-small cell lung cancer (201)
- Melanoma (199)
- Axon guidance (189)
- VEGF signaling pathway (187)
- Toll-like receptor signaling pathway (186)
- Endometrial cancer (185)
- Gap junction (181)
- Endocytosis (176)
- Adherens junction (173)
- Acute myeloid leukemia (171)
- Chronic myeloid leukemia (162)
- B cell receptor signaling pathway (156)
- Vascular smooth muscle contraction (154)
- Renal cell carcinoma (151)
- Calcium signaling pathway (148)
- Natural killer cell mediated cytotoxicity (147)
- mTOR signaling pathway (144)
- Epithelial cell signaling in Helicobacter pylori infection (142)
- Cytokine-cytokine receptor interaction (140)
- Bladder cancer (135)
- Long-term potentiation (131)
- Tight junction (130)
- Oocyte meiosis (129)
- Wnt signaling pathway (129)
- Adipocytokine signaling pathway (126)
- Melanogenesis (124)
- Cell cycle (119)
- Long-term depression (109)
- Apoptosis (100)
- NOD-like receptor signaling pathway (94)
- Small cell lung cancer (90)
- TGF-beta signaling pathway (89)
- Type II diabetes mellitus (87)
- Jak-STAT signaling pathway (77)
- Leukocyte transendothelial migration (76)
- RIG-I-like receptor signaling pathway (74)
- Dorso-ventral axis formation (69)
- p53 signaling pathway (67)
- Prion diseases (62)
- Thyroid cancer (55)
- Alzheimer's disease (49)
- Hedgehog signaling pathway (45)
- Pathogenic Escherichia coli infection (45)
- Vibrio cholerae infection (40)
- Amyotrophic lateral sclerosis (ALS) (39)
- Olfactory transduction (36)
- Primary immunodeficiency (30)
- Cytosolic DNA-sensing pathway (27)
- Hematopoietic cell lineage (27)
- Phosphatidylinositol signaling system (25)
- Regulation of autophagy (19)
- Viral myocarditis (18)
- Dilated cardiomyopathy (15)
- Taste transduction (15)
- Basal cell carcinoma (13)
- Hypertrophic cardiomyopathy (HCM) (12)
- PPAR signaling pathway (9)
- Nucleotide excision repair (8)
- Circadian rhythm - mammal (7)
- Non-homologous end-joining (5)
- Ubiquitin mediated proteolysis (5)
- Basal transcription factors (3)
- Parkinson's disease (2)